

Biopharma is seen as a safe haven for investors due to its high-margin business model and flexibility in dealing with potential tariffs. Other key questions...
You can purchase shares of State Street SPDR S&P Pharmaceuticals ETF (ARCA:XPH) through any online brokerage.
There are no as such competitors for State Street SPDR S&P Pharmaceuticals ETF.
There is no analysis for State Street SPDR S&P Pharmaceuticals ETF to provide a consensus price target.
The stock price for State Street SPDR S&P Pharmaceuticals ETF (ARCA: XPH) is $64.78 last updated November 6, 2026 at 3:12 PM EST.
There are no upcoming dividends for State Street SPDR S&P Pharmaceuticals ETF.
State Street SPDR S&P Pharmaceuticals ETF does not have any upcoming earnings scheduled.
There is no upcoming split for State Street SPDR S&P Pharmaceuticals ETF.
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the...